Northrop Grumman (NOC) Earnings Date & Reports

Northrop Grumman delivered robust Q1 2026 results for the quarter ended March 31, 2026. Sales reached $9.9 billion, a 4% increase from $9.5 billion in Q1 2025, with organic growth of 5%. This topped consensus estimates of about $9.8 billion, fueled by 17% sales growth in Aeronautics Systems to $3.3 billion, alongside gains in Defense Systems.

Diluted EPS climbed 85% to $6.14 from $3.32 YoY, exceeding forecasts near $6.07, while net earnings rose 82% to $875 million. Operating income jumped 73% to $989 million, lifting the margin to 10.0% from 6.1%, primarily due to no repeat of prior-year B-21 provisions at Aeronautics. Segment operating margins hit 10.8%, with Mission Systems at 15.1%.

Cash from operations was a use of $1.7 billion, similar to last year, reflecting working capital needs. Backlog stood at $95.6 billion, up slightly. The company reaffirmed 2026 guidance: sales $43.5-44 billion, adjusted EPS $27.40-27.90, and free cash flow (FCF) $3.1-3.5 billion.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your investment strategy.

Market Reaction and Investor Sentiment

Despite topping earnings and revenue expectations, Northrop Grumman shares declined about 3% in after-hours trading on April 21, 2026, with further pressure into April 22. The muted response may stem from reaffirmed guidance seen as steady but not aggressive, alongside broader defense sector rotation and valuation concerns. Pre-earnings sentiment was positive on backlog strength, but investors parsed margin details and cash use closely. Options activity showed caution, with volume spiking post-release.

Forward Outlook and Key Factors to Monitor

Northrop Grumman's reaffirmed 2026 guidance signals confidence in mid-single-digit sales growth, supported by a massive $95.6 billion backlog and key program ramps. Investors should track execution on high-priority contracts like the B-21 Raider, where recent U.S. Air Force agreements aim to boost production rates by 25%, and the Sentinel program accelerating toward initial operating capability.

Margin expansion remains pivotal, with Aeronautics targeting low-to-mid 9% and overall segment margins aiming for low-to-mid 11%. Free cash flow recovery to $3.1-3.5 billion will depend on working capital management and capex at $1.85 billion, up slightly for B-21 investments.

Broader dynamics include U.S. defense budget outcomes—FY2026 base funding up nearly 30% for key areas—and supply chain stability amid inflation. International demand and missile production volumes in Defense Systems could provide upside. Watch Q2 results for sustained organic growth and any guidance tweaks.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations